AKYA250117P12500
- 0.00
- 0.000.00%
Akoya Biosciences Newsroom
Akoya Biosciences Price Target Cut to $3.00/Share From $4.00 by Piper Sandler
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Cuts Target Price to $3
Morgan Stanley Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $3
Akoya Biosciences Is Maintained at Buy by Canaccord Genuity
Akoya Biosciences Analyst Ratings
Craig-Hallum Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Announces Target Price $5
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Maintains Target Price $4
Akoya Biosciences Downgraded to Hold From Buy at Craig-Hallum
Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)
CCORF Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Cuts Target Price to $3.5
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Announces Target Price $7
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Reaffirms Their Buy Rating on Akoya Biosciences (AKYA)
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Cuts Target Price to $4
Akoya Biosciences Analyst Ratings
Morgan Stanley Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Cuts Target Price to $3